Fort Myers, Fla., Feb. 18, 2021 – American Oncology Network, LLC (AON) is pleased to announce the opening of Cancer & Blood Specialists of Arizona in March 2021. The physicians, […]
Fort Myers, Fla., Feb. 8, 2021 – The American Oncology Network, LLC (AON), whose mission is to support the long-term viability of community oncology, is pleased to announce that Medical […]
Located in Columbus, Ohio, the Zangmeister Cancer Center offers comprehensive cancer and hematology treatment in three locations close to home. It adheres to a holistic approach while providing outpatient treatment […]
Fort Myers, Fla., Jan. 14, 2021 – American Oncology Network, LLC (AON), a high-growth oncology provider partners with the Community Oncology Alliance Patient Advocacy Network (CPAN) helping fight for patients […]
Fort Myers, Fla., Jan. 11, 2021 – Drs. Joseph Ye and Dong Xiang of Partner Oncology are pleased to announce that Medical Oncologist Xinda David Wang, MD, PhD has joined […]
This time of year is a time of thanks and gratitude, at Messino Cancer Centers the focus is on supporting their patients and community Asheville, N.C., Dec. 16, 2020, Messino […]
Low Country Cancer Care (LCCC), a leading community oncology and hematology practice, is opening a new comprehensive cancer care facility on Memorial Health’s campus to enhance services and provide improved conveniences for patients in Savannah and surrounding communities.
American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner practice Messino Cancer Centers (MCC), as a second strategic research site. Hematology/Oncology Clinic (HOC) in Baton Rouge, La., also a partner practice of AON, was the first strategic research site under this partnership.
Messino Cancer Centers (MCC), a partner practice of American Oncology Network, LLC (AON), recently aligned with the Sarah Cannon Research Institute, a global leader in offering community-based clinical trials.
Waverly Oncology Hematology (Waverly), an American Oncology Network, LLC (AON) partner, recently announced that the Journal of Clinical Oncology (JCO) has published the full results of the landmark MonarchE trial of abemaciclib (Verzenio®) combined with endocrine therapy for the adjuvant treatment of HR+, HER2-, node-positive, high risk, early breast cancer.
14543 Global Parkway
Suite 110
Fort Myers, FL 33913